Medicine guide

Quofenix

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Active substance
Delafloxacin
Made by
A. Menarini Industrie Farmaceutiche Riunite s.r.l.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Quofenix is indicated for the treatment of the following infections in adults: acute bacterial skin and skin structure infections (ABSSSI), community-acquired pneumonia (CAP), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byA. Menarini Industrie Farmaceutiche Riunite s.r.l.
Active substanceDelafloxacin
Used inAntibiotics, antivirals and antifungals taken into the body
ClassificationJ01MA23 · Antibiotics, antivirals and antifungals taken into the body
Authorised on2019-12-16
Last updated by the regulator2025-03-05
EMA product numberEMEA/H/C/004860

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).